+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

S1881 The Therapeutic Efficacy of Ursodeoxycholic Acid (Udca) in Drug-Induced Liver Injury: Results of a Randomized Controlled Trial



S1881 The Therapeutic Efficacy of Ursodeoxycholic Acid (Udca) in Drug-Induced Liver Injury: Results of a Randomized Controlled Trial



Gastroenterology 138(5): S-809




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067066181

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(10)63727-4


Related references

A randomized controlled trial of ursodeoxycholic acid udca in primary biliary cirrhosis pbc. European Journal of Clinical Investigation 19(2 Part 2): A15, 1989

Therapeutic options for drug induced liver injury: the efficacy of UDCA based on EBM. Nihon Shokakibyo Gakkai Zasshi 100(6): 659-666, 2003

Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial. Journal of Hepatology 13(Suppl. 2): S104, 1991

Role of ursodeoxycholic acid udca in liver injury induced in rats by carbon tetrachloride and ethanol et. Gastroenterology 100(5 Part 2): A797, 1991

P1317 : Efficacy of ursodeoxycholic acid as a volume reducing treatment for symptomatic polycystic liver disease: An international, multicenter, randomized controlled trial. Journal of Hepatology 62: S848-S849, 2015

Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial. Hepatobiliary and Pancreatic Diseases International 16(3): 296-302, 2018

Alpha interferon alpha ifn vs alpha ifn plus ursodeoxycholic acid udca in chronic hepatitis c ch c a controlled randomized trial. Journal of Hepatology 16(Suppl. 1): S48, 1992

A randomized trial comparing the combination ursodeoxycholic acid and colchicine to UDCA alone in primary biliary cirrhosis. Hepatology 20(4 Part 2): 151A, 1994

Ursodeoxycholic acid udca for treatment of primary biliary cirrhosis pbc interim analysis of a double blind multicenter randomized trial. Hepatology 10(4): 639, 1989

Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial. Journal of Gastroenterology and Hepatology 31(2): 409-416, 2016

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized, placebo-controlled trial. Gastroenterology 124(4): A708-A709, 2003

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis results of a randomized, placebo controlled trial. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 336, 2003

The Italian multi-centre randomized controlled trial of ursodeoxycholic acid vs ursodeoxycholic acid plus colchicine in symptomatic primary biliary cirrhosis. Hepatology 20(4 Part 2): 267A, 1994

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. Bmc Complementary and Alternative Medicine 15: 334, 2016

Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial. Journal of Gastroenterology 32(1): 56-62, 1997